Filing Details

Accession Number:
0001104659-21-011875
Form Type:
13G Filing
Publication Date:
2021-02-04 06:05:17
Filed By:
Saif Iv Healthcare (bvi) Ltd
Company:
Huize Holding Limited (NASDAQ:HUIZ)
Filing Date:
2021-02-04
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
SAIF IV Healthcare (BVI) Limited 190,232,260 0 190,232,260 0 190,232,260 18.3%
SAIF Partners IV 190,232,260 0 190,232,260 0 190,232,260 18.3%
SAIF IV GP 190,232,260 0 190,232,260 0 190,232,260 18.3%
SAIF IV GP Capital Ltd 190,232,260 0 190,232,260 0 190,232,260 18.3%
Andrew Y. Yan 190,232,260 0 190,232,260 0 190,232,260 18.3%
filing (i) SAIF IV Healthcare (BVI) Limited, (ii) SAIF Partners IV
Filing

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

(Rule 13d-102)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO § 240.13d-2

 

Under the Securities Exchange Act of 1934

(Amendment No.     )*

 

Huize Holding Limited

(Name of Issuer)

 

Class A common shares, par value $0.00001 per share

(Title of Class of Securities)

 

44473E105**

(CUSIP Number)

 

December 31, 2020

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

o            Rule 13d-1(b)

 

o            Rule 13d-1(c)

 

x           Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

** This CUSIP number applies to the American Depositary Shares (ADSs) of Huize Holding Limited (the Issuer), each representing 20 Class A common shares, par value $0.00001 per share, of the Issuer (Class A common shares).

 

The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (the Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 


 

CUSIP No. 44473E105**

13G

 

 

1

NAMES OF REPORTING PERSONS
SAIF IV Healthcare (BVI) Limited

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(SEE INSTRUCTIONS)                                                                                     (a)          
o            (b)           o

 

3

SEC USE ONLY

4

CITIZENSHIP OR PLACE OF ORGANIZATION
British Virgin Islands

 

NUMBER OF SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH

5

SOLE VOTING POWER
190,232,260
(1)

6

SHARED VOTING POWER
0

7

SOLE DISPOSITIVE POWER

190,232,260(1)

8

SHARED DISPOSITIVE POWER
0

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON

190,232,260(1)

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)                                                                                       
o

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
18.3%(2)

12

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
CO

 

 

 

 

(1)         Represents 190,232,260 Class A common shares in the form of 9,511,613 ADSs (excluding 45,638 ADSs contracted for sales as of December 31, 2020, which were all settled as of the date hereof) held by SAIF IV Healthcare (BVI) Limited, as further disclosed in Item 4.

 

(2)         This percentage is calculated based on 1,039,805,653 common shares issued and outstanding as of March 31, 2020, including (i) 889,214,446 Class A common shares, and (ii) 150,591,207 Class B common shares, as reported in the Issuers annual report on Form 20-F for the fiscal year ended December 31, 2019.  In respect of all matters subject to a shareholders vote, each Class A common share is entitled to one vote, and each Class B common share is entitled to 15 votes, voting together as a single class. Each Class B common share is convertible into one Class A common share at any time at the option of the holder thereof. Class A common shares are not convertible into Class B common shares under any circumstances.

 

1


 

CUSIP No. 44473E105**

13G

 

 

1

NAMES OF REPORTING PERSONS
SAIF Partners IV L.P.

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(SEE INSTRUCTIONS)                                                                                     (a)          
o            (b)           o

 

3

SEC USE ONLY

4

CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands

 

NUMBER OF SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH

5

SOLE VOTING POWER
190,232,260
(1)

6

SHARED VOTING POWER
0

7

SOLE DISPOSITIVE POWER

190,232,260(1)

8

SHARED DISPOSITIVE POWER
0

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON

190,232,260(1)                                                                                                                                 

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)                                                                                       
o

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
18.3%(2)

12

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN

 

 

 

 

(1)         Represents 190,232,260 Class A common shares in the form of 9,511,613 ADSs (excluding 45,638 ADSs contracted for sales as of December 31, 2020, which were all settled as of the date hereof) held by SAIF IV Healthcare (BVI) Limited, which is wholly owned by SAIF Partners IV L.P., as further disclosed in Item 4.

 

(2)         This percentage is calculated based on 1,039,805,653 common shares issued and outstanding as of March 31, 2020, including (i) 889,214,446 Class A common shares, and (ii) 150,591,207 Class B common shares, as reported in the Issuers annual report on Form 20-F for the fiscal year ended December 31, 2019.  In respect of all matters subject to a shareholders vote, each Class A common share is entitled to one vote, and each Class B common share is entitled to 15 votes, voting together as a single class. Each Class B common share is convertible into one Class A common share at any time at the option of the holder thereof. Class A common shares are not convertible into Class B common shares under any circumstances.

 

2


 

CUSIP No. 44473E105**

13G

 

 

1

NAMES OF REPORTING PERSONS
SAIF IV GP, L.P.

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(SEE INSTRUCTIONS)                                                                                     (a)          
o            (b)           o

 

3

SEC USE ONLY

4

CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands

 

NUMBER OF SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH

5

SOLE VOTING POWER
190,232,260
(1)

6

SHARED VOTING POWER
0

7

SOLE DISPOSITIVE POWER

190,232,260(1)

8

SHARED DISPOSITIVE POWER
0

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON

190,232,260(1)

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)                                                                                       
o

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
18.3%(2)

12

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN

 

 

 

 

(1)         Represents 190,232,260 Class A common shares in the form of 9,511,613 ADSs (excluding 45,638 ADSs contracted for sales as of December 31, 2020, which were all settled as of the date hereof) held by SAIF IV Healthcare (BVI) Limited, which is wholly owned by SAIF Partners IV L.P., whose general partner is SAIF IV GP, L.P., as further disclosed in Item 4.

 

(2)         This percentage is calculated based on 1,039,805,653 common shares issued and outstanding as of March 31, 2020, including (i) 889,214,446 Class A common shares, and (ii) 150,591,207 Class B common shares, as reported in the Issuers annual report on Form 20-F for the fiscal year ended December 31, 2019.  In respect of all matters subject to a shareholders vote, each Class A common share is entitled to one vote, and each Class B common share is entitled to 15 votes, voting together as a single class. Each Class B common share is convertible into one Class A common share at any time at the option of the holder thereof. Class A common shares are not convertible into Class B common shares under any circumstances.

 

3


 

CUSIP No. 44473E105**

13G

 

 

1

NAMES OF REPORTING PERSONS
SAIF IV GP Capital Ltd.

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(SEE INSTRUCTIONS)                                                                                     (a)          
o            (b)           o

 

3

SEC USE ONLY

4

CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands

 

NUMBER OF SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH

5

SOLE VOTING POWER
190,232,260
(1)

6

SHARED VOTING POWER
0

7

SOLE DISPOSITIVE POWER

190,232,260(1)

8

SHARED DISPOSITIVE POWER
0

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON

190,232,260(1)                                                                                                                                 

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)                                                                                       
o

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
18.3%(2)

12

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
CO

 

 

 

 

(1)         Represents 190,232,260 Class A common shares in the form of 9,511,613 ADSs (excluding 45,638 ADSs contracted for sales as of December 31, 2020, which were all settled as of the date hereof) held by SAIF IV Healthcare (BVI) Limited, which is wholly owned by SAIF Partners IV L.P., whose general partner is SAIF IV GP, L.P., whose general partner in turn is SAIF IV GP Capital Ltd., as further disclosed in Item 4.

 

(2)         This percentage is calculated based on 1,039,805,653 common shares issued and outstanding as of March 31, 2020, including (i) 889,214,446 Class A common shares, and (ii) 150,591,207 Class B common shares, as reported in the Issuers annual report on Form 20-F for the fiscal year ended December 31, 2019.  In respect of all matters subject to a shareholders vote, each Class A common share is entitled to one vote, and each Class B common share is entitled to 15 votes, voting together as a single class. Each Class B common share is convertible into one Class A common share at any time at the option of the holder thereof. Class A common shares are not convertible into Class B common shares under any circumstances.

 

4


 

CUSIP No. 44473E105**

13G

 

 

1

NAMES OF REPORTING PERSONS
Andrew Y. Yan

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(SEE INSTRUCTIONS)                                                                                     (a)          
o            (b)           o

 

3

SEC USE ONLY

4

CITIZENSHIP OR PLACE OF ORGANIZATION
Hong Kong

 

NUMBER OF SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH

5

SOLE VOTING POWER
190,232,260
(1)

6

SHARED VOTING POWER
0

7

SOLE DISPOSITIVE POWER

190,232,260(1)

8

SHARED DISPOSITIVE POWER
0

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON

190,232,260(1)

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)                                                                                       
o

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
18.3%(2)

12

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN

 

 

 

 

(1)         Represents 190,232,260 Class A common shares in the form of 9,511,613 ADSs (excluding 45,638 ADSs contracted for sales as of December 31, 2020, which were all settled as of the date hereof) held by SAIF IV Healthcare (BVI) Limited, which is wholly owned by SAIF Partners IV L.P., whose general partner is SAIF IV GP, L.P., whose general partner in turn is SAIF IV GP Capital Ltd., which is wholly owned by Andrew Y. Yan, as further disclosed in Item 4.

 

(2)         This percentage is calculated based on 1,039,805,653 common shares issued and outstanding as of March 31, 2020, including (i) 889,214,446 Class A common shares, and (ii) 150,591,207 Class B common shares, as reported in the Issuers annual report on Form 20-F for the fiscal year ended December 31, 2019.  In respect of all matters subject to a shareholders vote, each Class A common share is entitled to one vote, and each Class B common share is entitled to 15 votes, voting together as a single class. Each Class B common share is convertible into one Class A common share at any time at the option of the holder thereof. Class A common shares are not convertible into Class B common shares under any circumstances.

 

5


 

CUSIP No. 44473E105**

13G

 

 

Item 1(a)                                             Name of Issuer:

 

Huize Holding Limited

 

Item 1(b)                                             Address of Issuers principal executive offices:

 

5/F, Building 3-4

Shenzhen Animation Park, Yuehai Road, Nanhai Avenue

Nanshan District, Shenzhen 518052, Peoples Republic of China

 

Items 2(a)                                        Name of Reporting Persons filing:

 

(i) SAIF IV Healthcare (BVI) Limited,

(ii) SAIF Partners IV L.P.,

(iii) SAIF IV GP, L.P.,

(iv) SAIF IV GP Capital Ltd., and

(v) Andrew Y. Yan

(collectively, the Reporting Persons).

 

Item 2(b)                                             Address or principal business office or, if none, residence:

 

Suites 2516-2520, Two Pacific Place, 88 Queensway, Hong Kong

 

Item 2(c)                                              Citizenship:

 

(i) SAIF IV Healthcare (BVI) Limited British Virgin Islands
(ii) SAIF Partners IV L.P. Cayman Islands
(iii) SAIF IV GP, L.P. Cayman Islands
(iv) SAIF IV GP Capital Ltd. Cayman Islands
(v) Andrew Y. Yan Hong Kong

 

Item 2(d)                                             Title of class of securities:

 

Class A common shares, par value US$0.00001 per share

 

Item 2(e)                                              CUSIP No.:

 

44473E105. This CUSIP number applies to the ADSs of the Issuer, each representing 20 Class A common shares.

 

Item 3                                                            If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the persons filing is a:

 

Not applicable.

 

Item 4                                                            Ownership

 

The following information with respect to the ownership of Class A common shares of the Issuer by the Reporting Persons filing this statement on Schedule 13G was provided as of December 31, 2020.

 

Reporting Persons

 

Amount 
beneficially 
owned

 

Percent of
Class
(1)

 

Percent 
of
aggregate
voting
power
(2)

 

Sole Voting
Power

 

Shared
Voting
Power

 

Sole
Dispositive
Power

 

Shared
Dispositive
Power

 

SAIF IV Healthcare (BVI) Limited

 

190,232,260

(3)

18.3

%

6.0

%

190,232,260

 

0

 

190,232,260

 

0

 

SAIF Partners IV L.P.

 

190,232,260

(3)

18.3

%

6.0

%

190,232,260

 

0

 

190,232,260

 

0

 

SAIF IV GP, L.P.

 

190,232,260

(3)

18.3

%

6.0

%

190,232,260

 

0

 

190,232,260

 

0

 

SAIF IV GP Capital Ltd.

 

190,232,260

(3)

18.3

%

6.0

%

190,232,260

 

0

 

190,232,260

 

0

 

Andrew Y. Yan

 

190,232,260

(3)

18.3

%

6.0

%

190,232,260

 

0

 

190,232,260

 

0

 

 

6


 

CUSIP No. 44473E105**

13G

 

 


(1)               Calculation is based on 1,039,805,653 common shares issued and outstanding as of March 31, 2020, including (i) 889,214,446 Class A common shares, and (ii) 150,591,207 Class B common shares, as reported in the Issuers annual report on Form 20-F for the fiscal year ended December 31, 2019.  Each Class B common share is convertible into one Class A common share at any time at the option of the holder thereof. Class A common shares are not convertible into Class B common shares under any circumstances.

 

(2)               The percent of aggregate voting power beneficially owned by each Reporting Person is calculated by dividing the voting power beneficially owned by such Reporting Person by the voting power of all of Class A Common shares and Class B Common shares as a single class. In respect of all matters subject to a shareholders vote, each Class B Common share is entitled to 15 votes per share, whereas each Class A Common share is entitled to one vote.

 

(3)               Represents 190,232,260 Class A common shares in the form of 9,511,613 ADSs (excluding 45,638 ADSs contracted for sales as of December 31, 2020, which were all settled as of the date hereof) held by SAIF IV Healthcare (BVI) Limited, whose registered address is Kingston Chambers, PO Box 173, Road Town, Tortola, British Virgin Islands. SAIF IV Healthcare (BVI) Limited is wholly owned by SAIF Partners IV L.P., whose general partner is SAIF IV GP, L.P., whose general partner in turn is SAIF IV GP Capital Ltd., which is wholly owned by Andrew Y. Yan. Pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules promulgated thereunder, each of SAIF Partners IV L.P., SAIF IV GP, L.P., SAIF IV GP Capital Ltd. and Andrew Y. Yan may be deemed to beneficially own all of the shares of the Issuer owned by SAIF IV Healthcare (BVI) Limited. Andrew Y. Yan disclaims beneficial ownership of the shares held by SAIF IV Healthcare (BVI) Limited, except to the extent of his pecuniary interests therein.

 

Item 5                                                            Ownership of Five Percent or Less of a Class

 

Not applicable.

 

Item 6                                                            Ownership of More than Five Percent on Behalf of Another Person

 

Not applicable.

 

Item 7                                                            Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

 

Not applicable.

 

Item 8                                                            Identification and Classification of Members of the Group

 

Not applicable.

 

Item 9                                                            Notice of Dissolution of Group

 

Not applicable.

 

Item 10                                                     Certifications

 

Not applicable.

 

7


 

CUSIP No. 44473E105**

13G

 

 

SIGNATURES

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in the attached statement on Schedule 13G is true, complete and correct.

 

Dated: February 4, 2021

 

 

SAIF IV Healthcare (BVI) Limited

 

By:

SAIF Partners IV L.P., its Sole Shareholder

By:

SAIF IV GP, L.P., its General Partner

By:

SAIF IV GP Capital Ltd., its General Partner

 

By:

/s/ Andrew Y. Yan

 

 

Andrew Y. Yan, Sole Shareholder

 

 

 

SAIF Partners IV L.P.

 

By:

SAIF IV GP, L.P., its General Partner

By:

SAIF IV GP Capital Ltd., its General Partner

 

By:

/s/ Andrew Y. Yan

 

 

Andrew Y. Yan, Sole Shareholder

 

 

 

SAIF IV GP, L.P.

 

By:

SAIF IV GP Capital Ltd., its General Partner

 

By:

/s/ Andrew Y. Yan

 

 

Andrew Y. Yan, Sole Shareholder

 

 

 

SAIF IV GP Capital Ltd.

 

 

By:

/s/ Andrew Y. Yan

 

 

Andrew Y. Yan, Sole Shareholder

 

 

 

Andrew Y. Yan

 

/s/ Andrew Y. Yan

 

 

Andrew Y. Yan

 

 

8


 

CUSIP No. 44473E105**

13G

 

 

LIST OF EXHIBITS

 

Exhibit No.

 

Description

99.1

 

Joint Filing Agreement

 

9